Lopez discovers new mechanism for allopregnanolone inhibition of inflammatory signaling
Alejandro Lopez, a graduate research assistant at the Bowles Center for Alcohol Studies, has just discovered a new mechanism for allopregnanolone inhibition of inflammatory signaling. Allopregnanolone inhibits binding of lipopolysaccaride (LPS) to it’s binding site in the binding pocket of the toll-like receptor: Myeloid differentiation factor-2 (TLR4:MD2) protein complex with nanomolar affinity. Such high affinity … Read more